IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Abingworth LLP

Q2 2022 Holdings

Filed 2022-08-15 | 21 holdings | $312.4K | 13F-HR | View on SEC ↗ · Holdings Table ↗

Sign in to see sub-manager breakdown

IssuerClassCUSIPValue ↓Shares% Portfolio
Vaxcyte(PCVX)Common92243G108$90.7K4,168,71829.0%
Sierra OncologyCommon82640U107$72.3K1,314,12723.1%
Vera(VERA)Common92337R101$40.3K2,960,23112.9%
Adicet(TORCEUR)Common007002108$30.9K2,115,3859.9%
HillevaxCommon43157M102$19.9K1,838,4866.4%
Phathom(PHAT)Common71722W107$12.1K1,435,1063.9%
JasperCommon471871103$10.6K5,628,5583.4%
Verona(VRNA)SPONDS ADR925050106$10.2K2,457,5003.3%
eFFECTORCommon28202V108$6.5K4,822,1142.1%
Reneo(RPHM)Common75974E103$5.4K2,073,9571.7%
SolenoCommon834203200$3.2K18,022,6021.0%
Spruce BioCommonE5209E109$3.1K1,792,5181.0%
NucanaADR67022C106$2.4K3,333,3330.8%
ParatekCommon699374302$2.0K1,041,1310.6%
SientraCommon82621J105$1.4K1,673,5890.4%
Exicure(XCUR)Common30205M101$594281,6360.2%
Cymabay(CBAYUSD)Common23257D103$385131,0360.1%
Molecular TemplatesCommon608550109$182200,0000.1%
ObsevaCommonH5861P103$14187,9990.0%
Aeglea(AGLEUSD)Common00773J103$121240,5000.0%
OcugenCommon43358V109$167,1110.0%